|
Due to unforeseen circumstances, there has been a change to the speaker programme for the upcoming COVID-19 Vaccines webinar on 22 February 2021.
We are delighted to welcome Dr Kelly Lindert to the programme. Dr Lindert is the Senior Vice President of Clinical Development, Vaccines at Arcturus Therapeutics, where she leads the clinical development of the ARCT-021, a vaccine candidate designed to address SARS-CoV-2. She has previously worked at Moderna and Novartis Vaccines. Find out more about Dr Lindert and the other expert speakers on the website.
Attendees will be able to download a certifcate of attendance during the webinar.
Book your place today!
|
